Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. - Pascual-Pasto G; Bazan-Peregrino M; Olaciregui NG; Restrepo-Perdomo CA; Mato-Berciano A; Ottaviani D; Weber K; Correa G; Paco S; Vila-Ubach M; Cuadrado-Vilanova M; Castillo-Ecija H; et al. (Science translational medicine, 2019)